AZD-8309

N/A

Report date: 2022/01/24 09:15:50
NME

Base Information

Drug NameAZD-8309
Drug Alias NameAZD-8309
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCXC chemokine receptor antagonists
TargetsCXC chemokine receptor
Therapy Area/IndicationsPulmonary Disease, Chronic ObstructiveArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAstrazeneca Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAstrazeneca Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsPulmonary Disease, Chronic ObstructiveArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A